The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception

Sun Wook Moon, Eui Ho Park, Hye Rim Suh, Duk Hwan Ko, Yang In Kim, Hee Chul Han

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The systemic administration of opioids can be used for their strong analgesic effect. However, extensive activation of opioid receptors (ORs) beyond the targeted tissue can cause dysphoria, pruritus, and constipation. Therefore, selective activation of peripheral ORs present in the afferent fibers of the targeted tissue can be considered a superior strategy in opioid analgesia to avoid potential adverse effects. The purpose of this study was to clarify the role of peripheral kappa opioid receptors (kORs) in arthritic pain for the possible use of peripheral ORs as a target in anti-nociceptive therapy. We administered U50488 or nor-BNI/DIPPA, a selective agonist or antagonist of kOR, respectively into arthritic rat knee joints induced using 1% carrageenan. After the injection of U50488 or U50488 with nor-BNI or DIPPA into the inflamed knee joint, we evaluated nociceptive behavior as indicated by reduced weight-bearing on the ipsilateral limbs of the rat and recorded the activity of mechanosensitive afferents (MSA). In the inflamed knee joint, the intra-articular application of 1 μM, 10 nM, or 0.1 nM U50488 resulted in a significant reduction in nociceptive behavior. In addition, 1 μM and 10 nM U50488 decreased MSA activity. However, in a non-inflamed knee joint, 1 μM U50488 had no effect on MSA activity. Additionally, intra-articular pretreatment with 20 μM nor-BNI or 10 μM DIPPA significantly blocked the inhibitory effects of 1 μM U50488 on nociceptive behavior and MSA activity in the inflamed knee joint. These results implicate that peripheral kORs can contribute to anti-nociceptive processing in an inflamed knee joint.

Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalBrain Research
Volume1648
DOIs
Publication statusPublished - 2016 Oct 1

Fingerprint

kappa Opioid Receptor
Nociception
Knee Joint
Opioid Receptors
Opioid Analgesics
Arthritis
Joints
Carrageenan
Weight-Bearing
Constipation
Pruritus
Analgesia
Analgesics
Extremities
Pain
Injections
norbinaltorphimine
2-(3,4-dichlorophenyl)-N-methyl-N-(1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl)acetamide

Keywords

  • Carrageenan-induced arthritis
  • nor-BNI/DIPPA
  • Peripheral kappa opioid receptor
  • Single nerve recording
  • U50488
  • Weight-bearing

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception. / Moon, Sun Wook; Park, Eui Ho; Suh, Hye Rim; Ko, Duk Hwan; Kim, Yang In; Han, Hee Chul.

In: Brain Research, Vol. 1648, 01.10.2016, p. 11-18.

Research output: Contribution to journalArticle

@article{030a52fae1ba48cfbc5a76a90f05c291,
title = "The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception",
abstract = "The systemic administration of opioids can be used for their strong analgesic effect. However, extensive activation of opioid receptors (ORs) beyond the targeted tissue can cause dysphoria, pruritus, and constipation. Therefore, selective activation of peripheral ORs present in the afferent fibers of the targeted tissue can be considered a superior strategy in opioid analgesia to avoid potential adverse effects. The purpose of this study was to clarify the role of peripheral kappa opioid receptors (kORs) in arthritic pain for the possible use of peripheral ORs as a target in anti-nociceptive therapy. We administered U50488 or nor-BNI/DIPPA, a selective agonist or antagonist of kOR, respectively into arthritic rat knee joints induced using 1{\%} carrageenan. After the injection of U50488 or U50488 with nor-BNI or DIPPA into the inflamed knee joint, we evaluated nociceptive behavior as indicated by reduced weight-bearing on the ipsilateral limbs of the rat and recorded the activity of mechanosensitive afferents (MSA). In the inflamed knee joint, the intra-articular application of 1 μM, 10 nM, or 0.1 nM U50488 resulted in a significant reduction in nociceptive behavior. In addition, 1 μM and 10 nM U50488 decreased MSA activity. However, in a non-inflamed knee joint, 1 μM U50488 had no effect on MSA activity. Additionally, intra-articular pretreatment with 20 μM nor-BNI or 10 μM DIPPA significantly blocked the inhibitory effects of 1 μM U50488 on nociceptive behavior and MSA activity in the inflamed knee joint. These results implicate that peripheral kORs can contribute to anti-nociceptive processing in an inflamed knee joint.",
keywords = "Carrageenan-induced arthritis, nor-BNI/DIPPA, Peripheral kappa opioid receptor, Single nerve recording, U50488, Weight-bearing",
author = "Moon, {Sun Wook} and Park, {Eui Ho} and Suh, {Hye Rim} and Ko, {Duk Hwan} and Kim, {Yang In} and Han, {Hee Chul}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.brainres.2016.06.048",
language = "English",
volume = "1648",
pages = "11--18",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception

AU - Moon, Sun Wook

AU - Park, Eui Ho

AU - Suh, Hye Rim

AU - Ko, Duk Hwan

AU - Kim, Yang In

AU - Han, Hee Chul

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The systemic administration of opioids can be used for their strong analgesic effect. However, extensive activation of opioid receptors (ORs) beyond the targeted tissue can cause dysphoria, pruritus, and constipation. Therefore, selective activation of peripheral ORs present in the afferent fibers of the targeted tissue can be considered a superior strategy in opioid analgesia to avoid potential adverse effects. The purpose of this study was to clarify the role of peripheral kappa opioid receptors (kORs) in arthritic pain for the possible use of peripheral ORs as a target in anti-nociceptive therapy. We administered U50488 or nor-BNI/DIPPA, a selective agonist or antagonist of kOR, respectively into arthritic rat knee joints induced using 1% carrageenan. After the injection of U50488 or U50488 with nor-BNI or DIPPA into the inflamed knee joint, we evaluated nociceptive behavior as indicated by reduced weight-bearing on the ipsilateral limbs of the rat and recorded the activity of mechanosensitive afferents (MSA). In the inflamed knee joint, the intra-articular application of 1 μM, 10 nM, or 0.1 nM U50488 resulted in a significant reduction in nociceptive behavior. In addition, 1 μM and 10 nM U50488 decreased MSA activity. However, in a non-inflamed knee joint, 1 μM U50488 had no effect on MSA activity. Additionally, intra-articular pretreatment with 20 μM nor-BNI or 10 μM DIPPA significantly blocked the inhibitory effects of 1 μM U50488 on nociceptive behavior and MSA activity in the inflamed knee joint. These results implicate that peripheral kORs can contribute to anti-nociceptive processing in an inflamed knee joint.

AB - The systemic administration of opioids can be used for their strong analgesic effect. However, extensive activation of opioid receptors (ORs) beyond the targeted tissue can cause dysphoria, pruritus, and constipation. Therefore, selective activation of peripheral ORs present in the afferent fibers of the targeted tissue can be considered a superior strategy in opioid analgesia to avoid potential adverse effects. The purpose of this study was to clarify the role of peripheral kappa opioid receptors (kORs) in arthritic pain for the possible use of peripheral ORs as a target in anti-nociceptive therapy. We administered U50488 or nor-BNI/DIPPA, a selective agonist or antagonist of kOR, respectively into arthritic rat knee joints induced using 1% carrageenan. After the injection of U50488 or U50488 with nor-BNI or DIPPA into the inflamed knee joint, we evaluated nociceptive behavior as indicated by reduced weight-bearing on the ipsilateral limbs of the rat and recorded the activity of mechanosensitive afferents (MSA). In the inflamed knee joint, the intra-articular application of 1 μM, 10 nM, or 0.1 nM U50488 resulted in a significant reduction in nociceptive behavior. In addition, 1 μM and 10 nM U50488 decreased MSA activity. However, in a non-inflamed knee joint, 1 μM U50488 had no effect on MSA activity. Additionally, intra-articular pretreatment with 20 μM nor-BNI or 10 μM DIPPA significantly blocked the inhibitory effects of 1 μM U50488 on nociceptive behavior and MSA activity in the inflamed knee joint. These results implicate that peripheral kORs can contribute to anti-nociceptive processing in an inflamed knee joint.

KW - Carrageenan-induced arthritis

KW - nor-BNI/DIPPA

KW - Peripheral kappa opioid receptor

KW - Single nerve recording

KW - U50488

KW - Weight-bearing

UR - http://www.scopus.com/inward/record.url?scp=84978818299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978818299&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2016.06.048

DO - 10.1016/j.brainres.2016.06.048

M3 - Article

C2 - 27378583

AN - SCOPUS:84978818299

VL - 1648

SP - 11

EP - 18

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -